Authors:
GILTAY EJ
VANSCHAARDENBURG D
GOOREN LJG
VONBLOMBERG BME
FONK JCM
TOUW DJ
DIJKMANS BAC
Citation: Ej. Giltay et al., EFFECTS OF DEHYDROEPIANDROSTERONE ADMINISTRATION ON DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of rheumatology, 37(6), 1998, pp. 705-706
Citation: Dj. Touw et al., PHARMACOKINETIC MODELING OF INTRAVENOUS TOBRAMYCIN IN ADOLESCENT AND ADULT PATIENTS WITH CYSTIC-FIBROSIS USING THE NONPARAMETRIC EXPECTATION MAXIMIZATION (NPEM) ALGORITHM, Pharmacy world & science, 19(3), 1997, pp. 142-151
Authors:
TOUW DJ
JACOBS FAH
BRIMCOMBE RW
HEIJERMAN HGM
BAKKER W
BREIMER DD
Citation: Dj. Touw et al., PHARMACOKINETICS OF AEROSOLIZED TOBRAMYCIN IN ADULT PATIENTS WITH CYSTIC-FIBROSIS, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 184-187
Citation: D. Compas et al., RAPID METHOD FOR THE ANALYSIS OF ITRACONAZOLE AND HYDROXYITRACONAZOLEIN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 687(2), 1996, pp. 453-456
Authors:
VINKS AATMM
TOUW DJ
VANROSSEN RCJM
HEIJERMAN HGM
BAKKER W
Citation: Aatmm. Vinks et al., STABILITY OF AZTREONAM IN A PORTABLE PUMP RESERVOIR USED FOR HOME INTRAVENOUS ANTIBIOTIC-TREATMENT (HIVAT), Pharmacy world & science, 18(2), 1996, pp. 74-77
Authors:
TOUW DJ
VINKS AATMM
JACOBS F
HEIJERMAN HGM
BAKKER W
Citation: Dj. Touw et al., CREATININE CLEARANCE AS PREDICTOR OF TOBRAMYCIN ELIMINATION IN ADULT PATIENTS WITH CYSTIC-FIBROSIS, Therapeutic drug monitoring, 18(5), 1996, pp. 562-569
Authors:
TOUW DJ
VINKS AATMM
HEIJERMAN HGM
BAKKER W
Citation: Dj. Touw et al., PROSPECTIVE EVALUATION OF A DOSE PREDICTION ALGORITHM FOR INTRAVENOUSTOBRAMYCIN IN ADOLESCENT AND ADULT PATIENTS WITH CYSTIC-FIBROSIS, Therapeutic drug monitoring, 18(2), 1996, pp. 118-123
Citation: Dj. Touw et al., EVALUATION OF A FLUORESCENCE POLAROGRAPHIC IMMUNOASSAY WITH INCREASEDSENSITIVITY FOR MEASUREMENT OF LOW CONCENTRATIONS OF TOBRAMYCIN IN SERUM, Therapeutic drug monitoring, 18(2), 1996, pp. 189-193
Authors:
VINKS AATMM
MOUTON JW
TOUW DJ
HEIJERMAN HGM
DANHOF M
BAKKER W
Citation: Aatmm. Vinks et al., POPULATION PHARMACOKINETICS OF CEFTAZIDIME IN CYSTIC-FIBROSIS PATIENTS ANALYZED BY USING A NONPARAMETRIC ALGORITHM AND OPTIMAL SAMPLING STRATEGY, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1091-1097
Authors:
VINKS AATMM
TOUW DJ
HEIJERMAN HGM
DANHOF M
DELEEDE GPJ
BAKKER W
Citation: Aatmm. Vinks et al., PHARMACOKINETICS OF CEFTAZIDIME IN ADULT CYSTIC-FIBROSIS PATIENTS DURING CONTINUOUS-INFUSION AND AMBULATORY TREATMENT AT HOME, Therapeutic drug monitoring, 16(4), 1994, pp. 341-348
Authors:
TOUW DJ
VINKS AATMM
HEIJERMAN HGM
HERMANS J
BAKKER W
Citation: Dj. Touw et al., SUGGESTIONS FOR THE OPTIMIZATION OF THE INITIAL TOBRAMYCIN DOSE IN ADOLESCENT AND ADULT PATIENTS WITH CYSTIC-FIBROSIS, Therapeutic drug monitoring, 16(2), 1994, pp. 125-131